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Our two main intents in publication were to raise awareness about cosmetic gynecology and energy-based therapy. Let us begin with vaginal rejuvenation, the elephant in the room. As leaders of the International Urogynecological Association (IUGA) Special Interest Group in Cosmetic Gynecology, we understand just how severely a lack of standard definitions and objective cosmetic and functional outcomes has impaired development in this field. To address this, we have submitted a proposal to the IUGA Terminology and Standardization Committee that was accepted to begin a document on cosmetic gynecology. Then, once common definitions have been developed, a new, stronger foundation can be built, upon which comparative endpoints (safety and efficacy data) can be produced. BAcademic cosmetic gynecology^is not so much a new term as it is our pledge to help in the development of these objective measures.
In the interim, however, we cannot ignore this topic simply because there is no defined nomenclature. In 2016, Americans spent US$15 billion on cosmetic procedures, with 10,774 labiaplasties performed (a 23% increase since 2015) [2] . An ongoing systematic review (by author BA Garcia) suggests that 69% of these procedures are performed by plastic surgeons, with only 25% by gynecologists.
We absolutely agree that vigilance must be observed in the characterization and treatment of women with genitourinary syndrome of menopause. We further concur that a hypoestrogenic state is best treated with localized replacement of hormones and that it can be offered as an option for women with a history of breast cancer. The theoretical mechanism posited for the improvement of sexual function in women undergoing energy-based therapy, while intuitive, is admittedly in our editorial, conjecture. Most importantly, we agree that more objective, randomized, placebo-controlled research needs to be carried out to properly vet this technology.
Much like cosmetic gynecology, there is a breadth of information available that can be confusing, not only to patients but also to providers. Energy-based therapies are another therapeutic modality, an arrow to be added to our quiver of treatment options for urogynecological conditions. As we continue to develop research protocols and produce data, we will be able to take better aim and refine our treatment targets.
